
Pitney Bowes (PBI) Earnings Dates & Reports
Pitney Bowes (PBI) Most Recent Earnings
Report Date
Period EndingQ4 2025
Est. EPS$0.38
Actual EPS$0.45
EarningsBeat
Pitney Bowes (PBI) Earnings
View the latest Pitney Bowes (PBI) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Pitney Bowes (PBI)
Order type
Buy in
Order amount
Est. shares
0 shares
Pitney Bowes (PBI) Earnings per Share (EPS) History
Signup for full accessBrowse free
Pitney Bowes (PBI) Latest Earnings
The value each PBI share was expected to gain vs. the value each share gained.
Pitney Bowes (PBI) reported its most recent earnings on for Q4 2025, posting earnings per share (EPS) of $0.45. This exceeded analysts' expectations of $0.38 by 18.42%, marking a Beat.
For comparison, Pitney Bowes reported EPS of $0.32 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.02.
Pitney Bowes (PBI) Earnings History
Pitney Bowes (PBI) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Pitney Bowes’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Pitney Bowes (PBI) Earnings FAQs
Pitney Bowes (PBI) last reported earnings on Feb 2, 2026 for Q4 2025, posting an EPS of $0.45, which Beat the estimate of $0.38 by 18.42%.
For Q4 2025, Pitney Bowes (PBI) reported an EPS of $0.45, exceeding analysts' estimate of $0.38 by 18.42%.
For Q4 2025, Pitney Bowes (PBI) Beat expectations with an actual EPS of $0.45 vs. an estimated EPS of $0.38.
Following the last earnings report on Feb 2, 2026, Pitney Bowes (PBI)'s stock price moved — from — to —.
The next Pitney Bowes (PBI) earnings call is scheduled for May. 6, 2026, where executives will discuss financial results and outlook.